What is the debt of MaxCyte this year?
MaxCyte has a debt level of -46.51 USD this year.
MaxCyte Debt 2024
MaxCyte Debt
-46.51 USD
Ticker
MXCT
ISIN
US57777K1060
WKN
A2AGVE
In 2024, MaxCyte's total debt was -46.51 USD, a 318.97% change from the -11.1 USD total debt recorded in the previous year.
MaxCyte Aktienanalyse
What does MaxCyte do?
MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding MaxCyte's Debt Structure
MaxCyte's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing MaxCyte's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to MaxCyte’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in MaxCyte’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about MaxCyte Stock
What was the debt of MaxCyte compared to the previous year?
The debt of MaxCyte has increased by 318.97% compared to the previous year increased.
What are the consequences of high debt for investors in MaxCyte?
High debt can pose a risk for investors of MaxCyte, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of MaxCyte?
Low debt means that MaxCyte has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from MaxCyte affect the company?
An increase in debt of MaxCyte can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of MaxCyte affect the company?
A reduction in debt of MaxCyte can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of MaxCyte?
Some factors that can influence the debt of MaxCyte include investments, acquisitions, operating costs, and revenue development.
Why are the debts of MaxCyte so important for investors?
The debts of MaxCyte are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can MaxCyte take to change the debt?
To change the debt, MaxCyte can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does MaxCyte pay?
Over the past 12 months, MaxCyte paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MaxCyte is expected to pay a dividend of 0 USD.
What is the dividend yield of MaxCyte?
The current dividend yield of MaxCyte is .
When does MaxCyte pay dividends?
MaxCyte pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MaxCyte?
MaxCyte paid dividends every year for the past 0 years.
What is the dividend of MaxCyte?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is MaxCyte located?
MaxCyte is assigned to the 'Health' sector.
Wann musste ich die Aktien von MaxCyte kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MaxCyte from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.
When did MaxCyte pay the last dividend?
The last dividend was paid out on 6/30/2024.
What was the dividend of MaxCyte in the year 2023?
In the year 2023, MaxCyte distributed 0 USD as dividends.
In which currency does MaxCyte pay out the dividend?
The dividends of MaxCyte are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MaxCyte
Our stock analysis for MaxCyte Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MaxCyte Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.